Breast Cancer,TNBC (Triple Negative Breast Cancer) Durvalumab Combinations in TNBC: Promising Results with D+Paclitaxel (Phase 1b/2 Study) Jun 30, 2023
Breast Cancer,HER2-,TNBC (Triple Negative Breast Cancer) Interim Analysis of Phase III SASCIA Trial on SG in High-Risk HER2-Negative BC Jun 30, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) PD-L1 Expression Predicts Efficacy of PD-1/PD-L1 Inhibitors in Metastatic TNBC Jun 15, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Residual Cancer Burden Impacts EFS in Neoadjuvant Pembrolizumab + Chemo for Early TNBC Jun 15, 2023
Breast Cancer,HER2+ Margetuximab vs Trastuzumab in Pretreated ERBB2-Positive Advanced Breast Cancer Jun 08, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Pembrolizumab With Chemo in Japanese TNBC Patients: KEYNOTE-355 Study Findings Jun 08, 2023
Breast Cancer,HER2+ Examining the Potential of Margetuximab in the Treatment of HER2+ Metastatic Breast Cancer May 19, 2023
